Cigna Group Cash & Equivalents 2015-2026 | CI
Beta
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Cigna Group's current cash & equivalents?
Cigna Group (CI) annual cash & equivalents for 2025 was $7.74B, a 1.90% increase from 2024. Cigna Group cash & equivalents for the quarter ending March 31, 2026 was $7.08B.
What was Cigna Group's cash & equivalents in 2024?
Cigna Group annual cash & equivalents for 2024 was $7.59B, a 3.53% decline from 2023.
What was Cigna Group's cash & equivalents in 2023?
Cigna Group annual cash & equivalents for 2023 was $7.87B, a 31.69% increase from 2022.
What is Cigna Group's 5-year cash & equivalents CAGR?
Cigna Group cash & equivalents grew at a compound annual growth rate (CAGR) of 5.46% from FY2020 to FY2025, going from $10.24B to $7.74B over 5 years.
Cash & Equivalents History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-5.5%
FY2020
$10.24B
→
FY2025
$7.74B
1516171819202122232425
5 years selected
Company: Cigna GroupTicker: CISector: HealthcareIndustry: Hospital & Medical Service PlansView company profile →